CNMD Analyst Ratings
CONMED Corporation (CNMD) operates in the Healthcare sector, specifically the Medical - Devices industry, with a market capitalization near $1.07B, listed on NYSE, employing roughly 3,900 people, carrying a beta of 0.94 to the broader market. CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. Led by Patrick J. Beyer, public since 1987-07-23.
Consensus: Mixed from 0 analysts.
Price Targets
- Average Target
- $78.00
- High
- $95.00
- Low
- $61.00
Recent Upgrades & Downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 1, 2026 | Wells Fargo | maintain | Equal Weight | Equal Weight |
| Apr 30, 2026 | JP Morgan | maintain | Neutral | Neutral |
| Mar 17, 2026 | Piper Sandler | downgrade | Overweight | Neutral |
| Jan 29, 2026 | Needham | maintain | Hold | Hold |
| Jan 29, 2026 | Wells Fargo | maintain | Equal Weight | Equal Weight |
How to Read CNMD Analyst Coverage
Sell-side equity analysts publish three primary outputs: ratings (Strong Buy / Buy / Hold / Sell / Strong Sell, or firm-specific equivalents), price targets, and EPS / revenue estimate revisions. Rating consensus moves slowly relative to price; it reflects 12-month directional conviction rather than near-term momentum. Price targets are more responsive but typically drift behind realized price during sharp moves. The most actionable signal for options traders is a cluster of ratings actions across multiple firms within a short window, which compresses or expands implied volatility on a horizon of days to weeks and shifts the put-call skew toward the directional consensus. The recent-actions table above shows the five most recent firm-level changes; longer histories live behind aggregator sources.
For event-driven options sizing, pair the consensus rating and target distribution with the implied-volatility surface and dealer-positioning view. Aggressive target hikes from multiple firms tend to tighten put skew (downside protection becomes relatively cheaper); aggressive cuts widen put skew. The size of the IV response in the hours after a rating change is visible on the per-ticker volatility skew page and the gamma-exposure page, both of which show how dealer hedging propagates the analyst-driven flow into the listed options chain.
Learn how analyst ratings is reported and how to read the data →
Frequently asked CNMD analyst ratings questions
- What is the CNMD consensus price target?
- As of the latest aggregator update, CONMED Corporation (CNMD) carries a consensus 12-month price target of $78.00. Target ranges run from a low of $61.00 to a high of $95.00. The target is the average of the price targets published by sell-side equity analysts covering the name.
- What is the analyst rating consensus on CNMD?
- Analyst rating consensus is not currently available for CNMD.
- What recent ratings actions has CNMD seen?
- The five most recent ratings actions on CNMD appear on the page above. Sell-side rating changes are watched for two reasons: an upgrade or downgrade with a meaningful target revision moves the consensus and can trigger short-term positioning shifts, and the firm-level rating cluster (multiple firms moving in the same direction within a short window) is a clearer signal than any single action. Options markets often price the implied-vol response within minutes of the announcement.
- How do analyst targets affect CNMD options pricing?
- Analyst target revisions tend to be priced in by the lit options market within minutes of publication, but persistent target drift over weeks does correlate with implied-volatility movement. Aggressive target hikes from multiple firms inside a single quarter tighten put skew (downside protection becomes cheaper relative to upside speculation); aggressive cuts widen put skew. The most actionable read is the implied-vol response in the hours after a target change, which is visible on the per-ticker volatility skew page.